Premium
Is heart failure a debatable end‐point for biphosphonate treatment in older osteoporotic population?
Author(s) -
Canpolat U.,
Gökçay Canpolat A.,
Aras D.,
Aydoğdu S.
Publication year - 2014
Publication title -
journal of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.625
H-Index - 160
eISSN - 1365-2796
pISSN - 0954-6820
DOI - 10.1111/joim.12152
Subject(s) - medicine , raloxifene , heart failure , hazard ratio , myocardial infarction , bisphosphonate , osteoporosis , population , randomized controlled trial , confidence interval , cardiology , environmental health , cancer , estrogen receptor , breast cancer